Overview
Kathy Theall is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Theall is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are HER2 Negative Breast Cancer, Breast Cancer, and Infantile Neutropenia.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Sara Tolaney is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Tolaney is currently accepting new patients.
The General Hospital Corporation
Dejan Juric is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Juric is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Ovarian Cancer, Tissue Biopsy, and Lithotripsy. Dr. Juric is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Judy Garber is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Phacomatosis Pigmentokeratotica. Dr. Garber is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HER2 Negative Breast CancerDr. Theall isDistinguished. Learn about HER2 Negative Breast Cancer.
- Advanced
- Breast CancerDr. Theall isAdvanced. Learn about Breast Cancer.
- Experienced
- Infantile NeutropeniaDr. Theall isExperienced. Learn about Infantile Neutropenia.